Geneos Wealth Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
3,266
-4,789
-59% -$1.27M 0.03% 435
2026
Q1
$883K Buy
8,055
+204
+3% +$29.1K 0.02% 541
2025
Q4
$1.31M Buy
7,851
+381
+5% +$63.7K 0.03% 436
2025
Q3
$1.46M Sell
7,470
-1,450
-16% -$238K 0.04% 405
2025
Q2
$807K Buy
8,920
+4,887
+121% +$386K 0.02% 587
2025
Q1
$241K Buy
4,033
+3,761
+1,383% +$348K 0.01% 845
2024
Q4
$36K Buy
+272
New +$25.5K ﹤0.01% 1449

Other funds holding ALAB

Geneos Wealth Management's ALAB Position: Q2 2026 in Review

Geneos Wealth Management reduced its Astera Labs (ALAB) stake by 59% in Q2 2026, selling an estimated $1.27M and leaving 3,266 shares worth $1.58M. The position accounts for 0.03% of the portfolio, ranked #435.

Geneos Wealth Management first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 992 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Geneos Wealth Management held 3,266 shares of Astera Labs worth $1.58M as of Q2 2026.
  • Geneos Wealth Management sold 4,789 Astera Labs shares in Q2 2026, an estimated $1.27M.
  • Astera Labs made up 0.03% of Geneos Wealth Management's portfolio in Q2 2026, its #435 holding.
  • Geneos Wealth Management first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 992 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.